Sirio Pharma Co., Ltd.

300791

CNE100003NB0

Food Processing

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-07 pm EDT			5-day change	1st Jan Change
41.24 ^CNY	-0.82%		+5.66%	+18.98%

Apr. 21	Sirio Pharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 19	Tranche Update on Sirio Pharma Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023.	CI

Sirio Pharma Co., Ltd. Announces Implementation of Cash Dividend for the Year 2022, Payable on June 07, 2023

June 01, 2023 at 03:57 pm EDT

Sirio Pharma Co., Ltd. announced implemented final profit distribution of Cash dividend/10 A shares (tax included) is CNY 3.50000000 for the year 2022. Record date: 06 June 2023; Ex-date: 07 June 2023; Payment date: 07 June 2023.

Latest news about Sirio Pharma Co., Ltd.

Sirio Pharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 20	CI
Tranche Update on Sirio Pharma Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023.	Mar. 19	CI
Sirio Pharma Co., Ltd.'s Equity Buyback announced on September 15, 2023, has closed with 1,285,600 shares, representing 0.71% for CNY 39.9 million.	Mar. 17	CI
Tranche Update on Sirio Pharma Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023.	Jan. 02	CI
Sirio Pharma Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Certain A-Shares of Sirio Pharma Company Limited are subject to a Lock-Up Agreement Ending on 25-SEP-2023.	23-09-24	CI
Sirio Pharma Co., Ltd.(XSEC:300791) added to S&P Global BMI Index	23-09-18	CI
Sirio Pharma Co., Ltd. announces an Equity Buyback for CNY 40 million worth of its shares.	23-09-15	CI
Sirio Pharma Co., Ltd. authorizes a Buyback Plan.	23-09-13	CI
Sirio Pharma Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24	CI
Sirio Pharma Co., Ltd. Announces Implementation of Cash Dividend for the Year 2022, Payable on June 07, 2023	23-06-01	CI
Sirio Pharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Sirio Pharma Co., Ltd. Proposes Profit Distribution Proposal of Cash Dividend for the Year 2022	23-04-21	CI
Sirio Pharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-20	CI
Sirio Pharma Co., Ltd.(XSEC:300791) dropped from S&P Global BMI Index	22-12-19	CI
Sirio Pharma Cancels Planned 1.35 Billion Yuan Share Sale to Fund Aquisition	22-12-08	MT
Sirio Pharma Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25	CI
Sirio Pharma Co., Ltd. acquired 80% stake in Best Formulations Inc. from m Eugene C. Ung, Kelly C. Ung, Charles C. Ung, Peak Trust Company-NV, Jeffrey A. Goh, and Joy S. Hsu.	22-10-16	CI
Certain A-Shares of Sirio Pharma Company Limited are subject to a Lock-Up Agreement Ending on 25-SEP-2022.	22-09-24	CI
Sirio Pharma Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25	CI
Sirio Pharma to Buy 80% of US Rival Best Formulations for $180 Million; Shares Slump 4%	22-07-10	MT
Sirio Pharma Plans to Raise Up to CNY 1.35 Billion in Share Private Placement	22-07-07	CI
Sirio Pharma Co., Ltd. agreed to acquire 80% stake in Ultimate Formulations, Inc.	22-07-06	CI
Sirio Pharma Co., Ltd. announced that it expects to receive CNY 1.35 billion in funding	22-07-05	CI
Sirio Pharma Co., Ltd. Announces Final Profit Distribution Plan for 2021 on A Shares, Payable on 23 May 2022	22-05-17	CI

Chart Sirio Pharma Co., Ltd.

Duration

Period

More charts

Company Profile

Sirio Pharma Co., Ltd. is a China-based company principally engaged in the research and development, production and sales of nutritional health food. The Company's main products include soft capsules, tablets, powders, soft candy, hard capsules and oral liquids. The Company's own brand is WEWOW nutritional health food. The Company distributes its products both in the domestic market and to overseas markets.

Sector

Food Processing

Calendar

2024-05-28 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for Sirio Pharma Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

41.24 CNY

Average target price

41.67 CNY

Spread / Average Target

+1.03%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
SIRIO PHARMA CO., LTD.	+18.98%	1.04B
ZHEJIANG NHU COMPANY LTD.	+16.33%	8.43B
BELLRING BRANDS, INC.	+4.78%	7.65B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+13.22%	6.65B
BYHEALTH CO., LTD	-6.99%	3.78B
XIAMEN KINGDOMWAY GROUP COMPANY	+4.78%	1.39B
HERBALIFE LTD.	-32.44%	1.01B
USANA HEALTH SCIENCES, INC.	-16.01%	861M
JAMIESON WELLNESS INC.	-18.06%	772M
GRAPE KING BIO LTD	+1.92%	728M

Special Foods & Wellbeing Products